- Q3 2021 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptOct 22, 2021円3841 (-0.93%)Earnings
- Chugai Pharmaceutical Co Ltd Information Meeting on RONAPREVE TranscriptAug 26, 2021
- Q2 2021 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptJul 26, 2021円4176 (+1.19%)Earnings
- Chugai Pharmaceutical Co Ltd Information Meeting on Polivy TranscriptJun 03, 2021
- Q1 2021 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptApr 22, 2021円4388 (+3.74%)Earnings
- Full Year 2020 Chugai Pharmaceutical Co Ltd Earnings Presentation TranscriptFeb 04, 2021
- Chugai Pharmaceutical Co Ltd Digital Strategy Meeting TranscriptDec 02, 2020
- Q3 2020 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptOct 22, 2020円4156 (-3.46%)Earnings
- Chugai Pharmaceutical Co Ltd ESG Presentation TranscriptSep 29, 2020
- Chugai Pharmaceutical Co Ltd Information Meeting on ENSPRYNG Subcutaneous Injection TranscriptSep 14, 2020
- Q2 2020 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptJul 27, 2020円5095 (-1.96%)Earnings
- Q1 2020 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptApr 23, 2020円4410 (-0.38%)Earnings
- Full Year 2019 Chugai Pharmaceutical Co Ltd Earnings Presentation TranscriptJan 31, 2020
- Chugai Pharmaceutical Co Ltd Antibody Engineering Technologies Information Meeting TranscriptDec 09, 2019
- Q3 2019 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptOct 24, 2019円2830 (+1.07%)Earnings
- Chugai Pharmaceutical Co Ltd Information Meeting on Rozlytrek TranscriptSep 05, 2019
- Q2 2019 Chugai Pharmaceutical Co Ltd Earnings Presentation TranscriptJul 26, 2019
- Chugai Pharmaceutical Co Ltd FoundationOne CDx Information Meeting TranscriptJul 04, 2019
- Chugai Pharmaceutical Co Ltd ESG Presentation TranscriptJun 18, 2019
- Q1 2019 Chugai Pharmaceutical Co Ltd Earnings Call TranscriptApr 24, 2019円2293.33 (+0.44%)Earnings
Q1 2019 Chugai Pharmaceutical Co Ltd Earnings Call Transcript
Good evening, ladies and gentlemen. I am Toshiaki Itagaki from Chugai Pharmaceutical. Thank you very much for joining us from late afternoon. With regard to the presentation material, I have made some changes to the way results are described and moved some of the slides, which used to be in the main text to the appendix, as well as added some new ones. So I will point to them as I go along. I hope you will stay with us till the end.
Please take a look at Page 2. This is a 1-page summary of the results intended to make the result easier to see.
In this first quarter, we saw increased revenues and operating profit with profit posting a double-digit growth. We achieved record high Q1 results in terms of revenues, operating profits and net income.
Furthermore, strong progress has been made against the full year forecast announced at the beginning of the fiscal year. With 33.5% of the full year forecast already posted in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)